Interactions between GSK-3 and the pro-apoptotic Bim molecule have been shown to increase the pro-apoptotic effects of BCL2/BCLXL inhibitors in human myeloid leukemia cells which were also treated with PI3K inhibitors. This evidence concerns the gene BCL2L1 and myeloid leukemia.